Editorial response: Hyperlactatemia and hepatic steatosis as features of mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors

被引：59
|
作者：
Brinkman, K [1 ]
机构：
[1] Onze Lieve Vrouwe Gasthuis, Dept Internal Med, NL-1091 HA Amsterdam, Netherlands
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 01期
关键词：
D O I：
10.1086/313921
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：167 / 169
页数：3
相关论文
共 50 条
  • [41] Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors
    Sugiura, W
    Matsuda, M
    Matsuda, Z
    Abumi, H
    Okano, A
    Oishi, T
    Moriya, K
    Yamamoto, T
    Fukutake, K
    Mimaya, J
    Ajisawa, A
    Taki, M
    Yamada, K
    Nagai, Y
    JOURNAL OF HUMAN VIROLOGY, 1999, 2 (03) : 146 - 153
  • [42] Discontinuation of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy due to nucleoside analogue reverse transcriptase inhibitorrelated metabolic toxicity
    Haddow, L. J.
    Wood, C. W.
    Ainsworth, J. G.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2007, 18 (05) : 343 - 346
  • [43] Gastrointestinal permeability studies using combinations of rifampicin and nucleoside analogue reverse transcriptase inhibitors in rats
    Mariappan, T. T.
    Singh, Saranjit
    INDIAN JOURNAL OF PHARMACOLOGY, 2007, 39 (06) : 284 - 290
  • [44] Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection
    Mallal, SA
    John, M
    Moore, CB
    James, IR
    McKinnon, EJ
    AIDS, 2000, 14 (10) : 1309 - 1316
  • [45] Nucleoside Analogue Reverse Transcriptase Inhibitors Differentially Inhibit Human LINE-1 Retrotransposition
    Jones, R. Brad
    Garrison, Keith E.
    Wong, Jessica C.
    Duan, Erick H.
    Nixon, Douglas F.
    Ostrowski, Mario A.
    PLOS ONE, 2008, 3 (02):
  • [46] Dietary supplements in the treatment of nucleoside reverse transcriptase inhibitor-related mitochondrial toxicity
    Venhoff, N
    Setzer, B
    Lebrecht, D
    Walker, UA
    AIDS, 2002, 16 (05) : 800 - 802
  • [47] Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure
    Marcelin, AG
    Delaugerre, C
    Wirden, M
    Viegas, P
    Simon, A
    Katlama, C
    Calvez, V
    JOURNAL OF MEDICAL VIROLOGY, 2004, 72 (01) : 162 - 165
  • [48] Non-nucleoside reverse transcriptase inhibitor efavirenz activates PXR to induce hypercholesterolemia and hepatic steatosis
    Gwag, Taesik
    Meng, Zhaojie
    Su, Yipeng
    Helsley, Robert N.
    Park, Se-Hyung
    Wang, Shuxia
    Greenberg, Richard N.
    Zhou, Changcheng
    JOURNAL OF HEPATOLOGY, 2019, 70 (05) : 930 - 940
  • [49] Mitochondrial toxicity of anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs): In vitro assessment of the mechanism and comparison with tenofovir.
    Birkus, G
    Hitchcock, M
    Cihlar, T
    FASEB JOURNAL, 2002, 16 (05): : A958 - A958
  • [50] Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels
    De Felipe, B.
    Blanco, A.
    Soriano-Sarabia, N.
    Munoz-Fernandez, M. A.
    Genebat, M.
    Vallejo, A.
    Leal, M.
    INFECTION, 2008, 36 (03) : 266 - 270
12345